Viewing nowEsome 40 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
LNC Bio Co., Ltd.

MFDS item code 202001244 · Approved 2020.02.21 · Insurance code 060500540
Treatment and prevention of acid-related disorders, Helicobacter- and NSAID-related gastrointestinal disorders, ulcers, and recurrent bleeding
This medication is used for the treatment and maintenance therapy of gastroesophageal reflux disease, especially erosive reflux esophagitis. It is also used in combination with antibiotics effective in treating Helicobacter pylori infection-related duodenal and peptic ulcers. It helps in the short-term treatment of gastrointestinal symptoms associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs) and also aids in the treatment and prevention of gastric and duodenal ulcers. It is utilized for maintenance therapy to prevent rebleeding in patients with Zollinger-Ellison syndrome and gastric or duodenal ulcers, improving patient symptoms. It is effective in treating and preventing various conditions related to gastrointestinal diseases.
This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. 1) Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. In adults, 20 mg once daily may be taken as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. 2) Administer 20 mg of this medicine with 1 g of amoxicillin and 500 mg of clarithromycin twice daily for 7 days. 3) 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials exceeding 4 weeks have not been conducted. 4) Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg/day. Doses above 80 mg/day should be divided into 2 doses. 6) After initiation of prevention of rebleeding from gastric or duodenal ulcers by intravenous injection, administer 40 mg once daily for 4 weeks. Renal impairment: Dose adjustment is not necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal failure. Hepatic impairment: Dose adjustment is not necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. Older adults: Dose adjustment is not necessary.
Adolescents aged 12 years and older: Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. In adults, 20 mg once daily may be taken as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. Children younger than 12 years: There is no experience with administration of this medicine to children younger than 12 years.
This medication should not be administered to certain patients. For instance, individuals with an allergy or previous hypersensitivity reaction to this medication or its components, as well as certain antibiotics or medications used in Helicobacter pylori eradication therapy, should not take this product. It is also not recommended for breastfeeding women and those with a history of myocardial infarction. This medication can cause various side effects, commonly headaches, abdominal pain, diarrhea, and nausea. Rarely, serious side effects such as blood abnormalities, hypersensitivity reactions, mental symptoms, liver function abnormalities, and skin rashes have been reported. Regular monitoring is necessary for electrolyte imbalances such as hypomagnesemia, especially with long-term use. This drug may interact with other medications; therefore, it is essential to discuss concurrent medications with a physician or pharmacist. Care is needed when used with medications affecting blood coagulation, antiviral agents, antibiotics, antiepileptics, etc., and when starting or stopping this medication, blood concentration or effects must be closely observed. Data on the safety of this medication during pregnancy is limited; thus, it should be administered with caution to pregnant women, and it is recommended not to take this medication while breastfeeding. In case of overdose, no specific antidote is available; thus, treatment and general management based on symptoms are required. This medication should be kept out of reach of children, and transferring it to other containers should be avoided to maintain quality.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylaxis, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, alopecia, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reactions with eosinophilia and systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile associated diarrhea, abdominal bloating, allergic reactions, back pain, chest pain, substernal pain, facial edema, facial flushing, fatigue, flu-like illness, general edema, leg edema, lethargy, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, worsening of constipation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, elevated serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, earaches, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, nosebleeds, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatic polymyalgia, appetite loss, apathy, increased appetite, confusion, worsening of depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disturbance, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, dysosmia, taste loss, taste disturbance, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infections, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent exposure to air or moisture and should be kept at a temperature between 1°C and 30°C.
Pink round film-coated tablet
28 tablets/box [28 tablets (14 tablets/PTP x 2)], 30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
LNC Bio Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.